Hilton Capital Management »

West Pharmaceutical Services shares owned by Hilton Capital Management

Quarter-by-quarter ownership of West Pharmaceutical Services (WST) shares owned by Hilton Capital Management from 13F filings

Historical chart of Hilton Capital Management investment in West Pharmaceutical Services

Tip: Access up to 7 years of quarterly data

All positions including West Pharmaceutical Services held by Hilton Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in West Pharmaceutical Services by Hilton Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 4.1k 300.16
2024-03-31 $2.0M 5.1k 395.71
2023-12-31 $794k 2.3k 352.12
2023-06-30 $244k 639 382.47

More positions owned by Hilton Capital Management

Vanguard S/t Corp Bond Etf Fixed Income ETF (VCSH)
Ishares Mbs Etf Fixed Income ETF (MBB)
Janus Henderson Aaa Clo Etf Fixed Income ETF (JAAA)
Jpm Nasdaq Equity Premium Income Etf Equity ETFs (JEPQ)
Ishares S&p Preferred Stock Index Fund Preferred Stock (PFF)
Spdr Blackstonesenior Loan Etf Fixed Income ETF (SRLN)
Vanguard Int-term Corp Bond Etf Fixed Income ETF (VCIT)
Simplify Mbs Etf Fixed Income ETF (MTBA)
Microsoft Common Stocks (MSFT)
Apple Common Stocks (AAPL)
Alerian Mlp Etf Equity ETFs (AMLP)
Utilities Select Sector Spdr Equity ETFs (XLU)
Nvidia Corp Common Stocks (NVDA)
Ishares 3-7 Yr Treasury Bd Etf Fixed Income ETF (IEI)
Vanguard Short Term Treasury Fixed Income ETF (VGSH)

View all positions for Hilton Capital Management

Top funds holding West Pharmaceutical Services

Vanguard Group
BlackRock
BlackRock
Bank of New York Mellon
State Street Corporation
Artisan Partners Limited Partnership
Franklin Resources
Alliancebernstein
Brown Advisory Holdings Incorporated
Geode Capital Management
T. Rowe Price Associates
Durable Capital Partners
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Findlay Park Partners

View all funds holding West Pharmaceutical Services